Digital Events | Kisaco Research
Filter by:
Animal Microbiome UK 2020
8-10 Sep 2020
Virtual Event
The Global Probiotics in Animal Feed Market is poised to grow at a CAGR of around 7.9% over the next decade to reach approximately $6.37 billion by 2025.The European Animal Microbiome Congress brings together leading veterinary researchers, innovative biotechnology companies, feed and strain manufacturers, animal breeders and producers, animal pharmaceutical companies, regulatory bodies, and cutting-edge solution providers to showcase the latest commercially viable research focusing on manipulating the animal microbiome, form successful product development strategies, and facilitate collaborations and business partnering.Techniques and products that manipulate the animal microbiome are set to be the next frontier in superior disease therapeutics, diagnostics, and nutrition in livestock, companion animals, and aquaculture. This conference will showcase unpublished data, new technologies, and translational case studies presented by leading academic and industry experts. 
Microbiome Connect - Skin - EU 2020
10-11 Nov 2020
Previously known as The Skin Microbiome Congress, Microbiome Connect: Skin EU's mission is to connect you with the leading personal care, biotech and pharma companies, with the aim of developing clinically & commercially viable cosmetics & therapeutics to revolutionise dermatology & skin health.Our 2020 Virtual Programme includes L'Oreal, Unilever, Johnson & Johnson, P&G, Walgreens Boots Alliance, University of Antwerp, Reckitt Benckiser, Bayer Pharmaceuticals & more who recognise the commercial value of skin microbiome-based product claims & formulations.On top of our all-star line up, we have 6 new topics to explore:Skin-Gut Axis & the development of Ingestible Beauty productsPersonalisation of skin-microbiome products & formulation considerationsMarketing & defining skin microbiome terminology to develop scientifically backed claims that resonate with consumersNext generation sequencing techniques & application in claims developmentNew Data demonstrating the role of the microbiome in common skin conditions including acne, eczema & dandruffVaginal & Oral Microbiomes - the mass-market product development opportunities to treat gingivitis/periodontitis & sexually transmitted infections (STIs).
Filter by:
Microbiome Connect : Human - USA 2020
3-5 Jun 2020
The gut microbiome is becoming an increasingly important druggable target for pharma companies through a range of modalities from FMT to small molecule and even phage. 2020 looks set to be a pivotal year for the microbiome industry with a handful of companies (including Seres, Rebiotix and Finch Therapeutics) set to release ground-breaking phase 3 clinical data. We’re a step away from market approval, but there’s still so much to learn…Major advances in shotgun metagenomic sequencing and computational biology allow us to see what’s going on at a strain-specific and metabolomic level of detail. Elucidating the key metabolites and mechanisms of action in both extra-intestinal and intestinal indications is a key objective in 2020/2021 and is a cornerstone of the discussion at Microbiome Connect: Human. Join key opinion leaders to examine the latest preclinical and clinical data in extra-intestinal and intestinal indications. This is your opportunity to translate gut-microbiome research into therapeutics that have the power to treat oncological, neurological, gastro-intestinal & metabolic diseases.Previously known as North American Microbiome Congress, Microbiome Connect: Human USA is all about connecting leading academics and biotech companies presenting preclinical and clinical data, to network, educate and share knowledge. 
Microbiome Connect - Skin - USA 2020
3-5 Jun 2020
2019 was a pivotal year for the skin microbiome, with multinational conglomerates moving into the space, recognizing the commercial value of skin microbiome-based products as the next step in a consumer’s skincare regime but the innovation doesn’t end there…This year is all about the major advancements of sequencing and analysis in this space, and how we can use data to inform product development. 2020 is all about the relationship between skin microbiome based-products, skin conditions, personalization, skin-gut supplements, and anti-aging. Building on the hugely successful global Skin Microbiome series which brought together over 600 industry leaders from Pharmaceutical, Beauty and Personal Care, Independent Skincare Brands, Bio-techs, Researchers and Academics, Kisaco Research presents Microbiome Connect: Skin USA, an all-encompassing event, which runs alongside Microbiome Connect: Human USA as a virtual event, June 3 - 5.What’s different?This year, you can expect 5 unique topics, more attendees and more networking opportunities to explore:Ground-breaking research into how best treat these skin diseases and develop treatments targeting acne vulgaris, atopic dermatitis, psoriasis Vulgaris and rosacea.The translation and commercialization of product claims, the latest trends and protecting your intellectual property.The convergence between the skin-gut axis and the supplement market.Personalized formulation and product developmentTools to increase product claims using sequencing and bioinformatics.Join key opinion leaders and expert speakers across three days to translate the latest skin microbiome data and market analysis into truly commercial and competitive beauty and personal care products.Skin microbiome based-products have been disrupting the beauty industry for the past two years, the question is, how can you differentiate your products?